Annual EBITDA
$1.33B$249.56M+23.20%
Summary
- Current Value
- As of today, GMAB annual EBITDA is $1.33B, up +23.20% on
- Historical Performance
- GMAB annual EBITDA is up +42.22% over the past 3 years, up +32.11% over the past 5 years
- All-Time High Comparison
- GMAB annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GMAB annual EBITDA is +61.69% above its 3-year low of $819.51M reached on
- Sector Comparison
- GMAB annual EBITDA is higher than 94.14% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.33B | +23.2% | +42.2% | +32.1% | +10000.0% | |
| Quarterly EBITDA | $254.94M | +24.9% | – | – | +2473.0% | |
| TTM EBITDA | $1.37B | +59.3% | – | – | +10000.0% | |
| Price | $26.88 | +29.2% | -33.8% | -33.2% | +1891.1% | |
| PE Ratio | 20.27 | +71.8% | -44.8% | -34.8% | – | |
| Annual Revenue | $3.73B | +19.5% | +82.1% | +141.3% | +3512.1% | |
| Annual EPS | $1.54 | -12.4% | +32.0% | +39.5% | +1312.3% | |
| $1.25B | +23.5% | +40.8% | +29.9% | +10000.0% | ||
| Annual Net Income | $965.95M | -15.1% | +25.4% | +32.8% | +3897.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.33B | at high | |
| 5Y | $1.33B | at high | |
| All | $1.33B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $819.51M | +61.7% | |
| 5Y | $519.39M | +155.1% | |
| All | -$137.28M | +1065.2% |
EBITDA History
FAQ
What is the current annual EBITDA of GMAB?
As of today, GMAB annual EBITDA is $1.33B
What is 1-year change in GMAB annual EBITDA?
GMAB annual EBITDA is up +23.20% year-over-year
What is 3-year change in GMAB annual EBITDA?
GMAB annual EBITDA is up +42.22% over the past 3 years
How far is GMAB annual EBITDA from its all-time high?
GMAB annual EBITDA is currently at its all-time high
How does GMAB annual EBITDA rank versus sector peers?
GMAB annual EBITDA is higher than 94.14% of companies in Healthcare sector
When is GMAB next annual earnings release?
As of today, the next annual earnings release for GMAB has not been scheduled
Quarterly EBITDA
$254.94M$8.89M-3.37%
Summary
- Current Value
- As of today, GMAB quarterly EBITDA is $254.94M, down -3.37% on
- Historical Performance
- GMAB quarterly EBITDA is up +24.88% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GMAB quarterly EBITDA is currently -61.68% below its historical high of $665.22M set on
- 3-Year Low Comparison
- GMAB quarterly EBITDA is +24.88% above its 3-year low of $204.14M reached on
- Sector Comparison
- GMAB quarterly EBITDA is higher than 92.88% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $254.94M | -3.4% | +24.9% | – | – | |
| Annual EBITDA | $1.33B | – | +23.2% | +42.2% | +32.1% | |
| TTM EBITDA | $1.37B | +3.8% | +59.3% | – | – | |
| Price | $26.88 | -8.1% | +29.2% | -33.8% | -33.2% | |
| PE Ratio | 20.27 | +7.3% | +71.8% | -44.8% | -34.8% | |
| Quarterly Revenue | $899.32M | -14.9% | +25.7% | +120.1% | +251.2% | |
| Quarterly EPS | $0.08 | +80.7% | -72.7% | +81.1% | -69.0% | |
| $225.83M | -7.0% | +20.0% | +275.7% | +162.1% | ||
| Quarterly Net Income | $53.20M | +71.7% | -72.7% | +75.7% | -70.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $474.87M | -46.3% | |
| 3Y | $474.87M | -46.3% | |
| 5Y | $474.87M | -46.3% | |
| All | $665.22M | -61.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $204.14M | N/A | +24.9% |
| 3Y | $204.14M | +24.9% | |
| 5Y | $204.14M | +24.9% | |
| All | -$59.21M | +530.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GMAB?
As of today, GMAB quarterly EBITDA is $254.94M
What is GMAB quarterly EBITDA most recent change?
GMAB quarterly EBITDA was down -3.37% on March 31, 2026
What is 1-year change in GMAB quarterly EBITDA?
GMAB quarterly EBITDA is up +24.88% year-over-year
How far is GMAB quarterly EBITDA from its all-time high?
GMAB quarterly EBITDA is currently -61.68% below its historical high of $665.22M set on June 30, 2020
How does GMAB quarterly EBITDA rank versus sector peers?
GMAB quarterly EBITDA is higher than 92.88% of companies in Healthcare sector
When is GMAB next earnings release?
The next earnings release for GMAB is on
TTM EBITDA
$1.37B$50.80M+3.84%
Summary
- Current Value
- As of today, GMAB TTM EBITDA is $1.37B, up +3.84% on
- Historical Performance
- GMAB TTM EBITDA is up +59.34% year-over-year, with unknown 3-year change
- All-Time High Comparison
- GMAB TTM EBITDA is currently -1.12% below its historical high of $1.39B set on
- 3-Year Low Comparison
- GMAB TTM EBITDA is +431.89% above its 3-year low of $258.46M reached on
- Sector Comparison
- GMAB TTM EBITDA is higher than 93.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.37B | +3.8% | +59.3% | – | – | |
| Annual EBITDA | $1.33B | – | +23.2% | +42.2% | +32.1% | |
| Quarterly EBITDA | $254.94M | -3.4% | +24.9% | – | – | |
| Price | $26.88 | -8.1% | +29.2% | -33.8% | -33.2% | |
| PE Ratio | 20.27 | +7.3% | +71.8% | -44.8% | -34.8% | |
| TTM Revenue | $3.91B | +4.9% | +21.0% | +83.6% | +135.8% | |
| TTM EPS | $1.33 | -14.3% | -24.8% | +19.8% | +2.5% | |
| $1.29B | +3.0% | +20.0% | +49.2% | +25.6% | ||
| TTM Net Income | $823.88M | -14.7% | -27.4% | +12.8% | -3.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.39B | -1.1% | |
| 3Y | $1.39B | -1.1% | |
| 5Y | $1.39B | -1.1% | |
| All | $1.39B | -1.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $862.77M | N/A | +59.3% |
| 3Y | $258.46M | +431.9% | |
| 5Y | $258.46M | +431.9% | |
| All | -$153.23M | +997.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GMAB?
As of today, GMAB TTM EBITDA is $1.37B
What is GMAB TTM EBITDA most recent change?
GMAB TTM EBITDA was up +3.84% on March 31, 2026
What is 1-year change in GMAB TTM EBITDA?
GMAB TTM EBITDA is up +59.34% year-over-year
How far is GMAB TTM EBITDA from its all-time high?
GMAB TTM EBITDA is currently -1.12% below its historical high of $1.39B set on September 30, 2025
How does GMAB TTM EBITDA rank versus sector peers?
GMAB TTM EBITDA is higher than 93.90% of companies in Healthcare sector
When is GMAB next earnings release?
The next earnings release for GMAB is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- GMAB Official Website www.genmab.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1434265/000143426526000014/0001434265-26-000014-index.htm
- GMAB Profile on Yahoo Finance finance.yahoo.com/quote/GMAB
- GMAB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmab